Thank You

Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. As a leader in drug development, SCRI is at the forefront of bringing cutting-edge therapies to community clinicians and patients close to home.

We offer: 

• End-to-end clinical trial site management all in one place – from our contract research organization (CRO) SCRI Development Innovations
• Centralized clinical trial support services through our site management organization (SMO)
• Personalized Medicine program that transforms real-world data into actionable insights 
• Services to improve clinical trial diversity and access

Our academically-trained clinical researchers are key opinion leaders in oncology and experts in their disease sites. They serve as investigators for clinical trials across various solid tumor and hematologic malignancies, provide expertise across SCRI’s research network in the U.S. and connect via SCRI’s executive disease site research committees.